Piramal Pharma Performance
- Today's Low
- ₹158
- Today's High
- ₹162
- 52 Week Low
- ₹132
- 52 Week High
- ₹221
- Open Price₹160
- Previous Close₹160
- Volume4,540,136
- 50 DMA₹164.88
- 100 DMA₹165.08
- 200 DMA₹172.18
Piramal Pharma Chart
Investment Returns
- Over 1 Month -8.27%
- Over 3 Month + 17.08%
- Over 6 Month -7.23%
- Over 1 Year -17.25%
Smart Investing Starts Here Start SIP with Piramal Pharma for Steady Growth!
Piramal Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -64.9
- PEG Ratio
- 0.1
- Market Cap Cr
- 21,155
- P/B Ratio
- 2.6
- Average True Range
- 5.94
- EPS
- 0
- Dividend Yield
- 0.1
- MACD Signal
- -0.55
- RSI
- 39.29
- MFI
- 38.41
Latest Stock News Updates
Piramal Pharma is avoiding the crowded GLP-1 peptide market, focusing instead on niche therapies and specialised manufacturing to drive CDMO growth in FY27
- Business Standard
- 5 days 8 hours ago
- Business Line
- 1 month ago
- Business Line
- 1 month 2 weeks ago
Piramal Pharma Financials
Piramal Pharma Technicals
EMA & SMA
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹165.90
- 50 Day
- ₹164.90
- 100 Day
- ₹165.10
- 200 Day
- ₹172.20
Resistance and Support
- R3 165.20
- R2 163.64
- R1 161.27
- S1 157.34
- S2 155.78
- S3 153.41
Piramal Pharma Corporate Actions - Bonus, Splits, Dividends
About Piramal Pharma
- NSE Symbol
- PPLPHARMA
- BSE Symbol
- 543635
- ISIN
- INE0DK501011
Similar Stocks to Piramal Pharma
Popular Stocks
Piramal Pharma FAQs
Piramal Pharma share price is ₹158 As on 20 June, 2026 | 07:50
The Market Cap of Piramal Pharma is ₹21155.1 Cr As on 20 June, 2026 | 07:50
The P/E ratio of Piramal Pharma is -64.9 As on 20 June, 2026 | 07:50
The PB ratio of Piramal Pharma is 2.6 As on 20 June, 2026 | 07:50
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.